Table 1 Correlation between serum CCAT2 relative expression and clinicopathological features of CC patients
From: Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer
Clinicopathologicfeatures | n= | CCAT2 relative expression | P value |
|---|---|---|---|
[median (upper and lower quartile)] | |||
Total (n) | 180 | ||
Age (yr) | 0.222 | ||
≤50 | 79 | 1.434 (1.050, 2.343) | |
>50 | 101 | 1.679 (1.079, 2.131) | |
Menopause | 0.460 | ||
yes | 94 | 1.586 (1.043, 2.282) | |
no | 86 | 1.675 (1.110, 2.219) | |
Tumor size | 0.101 | ||
≤4cm | 90 | 1.357 (1.021, 2.129) | |
>4cm | 90 | 1.749 (1.181, 2.343) | |
FIGO stage | 0.038* | ||
IA1-Ib1 | 63 | 1.283 (1.007, 2.056) | |
Ib2-IIa2 | 112 | 1.722 (1.189, 2.298) | |
≥IIb | 5 | 3.411 (1.052, 3.822) | |
Pathological type | 0.263 | ||
aquamous Ca | 152 | 1.675 (1.110, 2.131) | |
adenal Ca | 22 | 1.503 (1.021, 3.541) | |
adenosqua. Ca | 6 | 1.153 (0.924, 1.357) | |
SCC-Ag (ng/ml) | 0.001* | ||
negative | 98 | 1.352 (1.014, 1.866) | |
positive | 82 | 1.886 (1.266, 2.453) | |
LNM | 0.046* | ||
negative | 150 | 1.517 (1.047, 2.129) | |
positive | 30 | 1.904 (1.257, 2.596) |